Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Rerouting alkylating agents to the mitochondria for cancer therapy
EF 2011-12
Résumé
Mitochondria play a vital role inside our cells. They regulate various cellular processes that are important for the life and death of a cell. Due to the the critical function that mitochondria have, targeting drugs to the mitochondria of cancer cells could lead to improved drug potency. Recently, we have proven this principle by targeting a common cancer drug, used for the treatment of chronic lymphocytic leukemia, to the mitochondria. Our results indicated enhanced drug activity even in drug resistant cancer models. This project aims at understanding this increase in drug toxicity and further enhancing our novel drug compound. We will also test other common cancer drugs on the market to determine if mitochondria-targeting enhances their potency. The results from this study could help identify novel drug targets within the mitochondria that could be used to develop a new line of cancer therapeutics. This new class of chemotherapy drugs could provide cancer patients with a better therapeutic option and hopefully a greatly improved prognosis.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
247842
Name
Mourtada Rida
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Rerouting alkylating agents to the mitochondria for cancer therapy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Alkylating Agents; Chlorambucil; Drug Delivery; Mitochondria-Penetrating Peptides; Mitochondrial Dna; Mitochondriotropic Drugs
Abstract
Mitochondria play a vital role inside our cells. They regulate various cellular processes that are important for the life and death of a cell. Due to the the critical function that mitochondria have, targeting drugs to the mitochondria of cancer cells could lead to improved drug potency. Recently, we have proven this principle by targeting a common cancer drug, used for the treatment of chronic lymphocytic leukemia, to the mitochondria. Our results indicated enhanced drug activity even in drug resistant cancer models. This project aims at understanding this increase in drug toxicity and further enhancing our novel drug compound. We will also test other common cancer drugs on the market to determine if mitochondria-targeting enhances their potency. The results from this study could help identify novel drug targets within the mitochondria that could be used to develop a new line of cancer therapeutics. This new class of chemotherapy drugs could provide cancer patients with a better therapeutic option and hopefully a greatly improved prognosis.
Competitiondate
201111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mourtada, Rida
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~